Project Grant K01DA058152

Award Date 8/1/24
Completion Date 7/31/29
Dollars Obligated $376K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Boulder, CO 80309, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,726,432 to study the co-use of cannabis and prescription opioids among emerging adults ages 18-25 in medical settings. The 5-year study, beginning in September 2024, will enroll emerging adults with and without a history of cannabis use who are prescribed opioids for acute pain management. The research aims to identify risk and...
This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a 5-year human laboratory study to investigate the effects of repeated cannabidiol (CBD) administration on the abuse-related and analgesic properties of smoked cannabis in healthy adult cannabis smokers. The $541,080 award will support a randomized, counterbalanced study where 72 participants will receive one of four CBD doses (0,...
This Project Grant award for $2,838,472 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a prospective mixed-methods investigation to characterize cannabis use trajectories among young adults aged 18-25. The study aims to identify factors associated with hazardous cannabis use and understand how micro-transitions and critical life events during young adulthood influence changes in cannabis use patterns. Applying a...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding a $395,995 longitudinal study to examine the bidirectional relationship between cannabis use, sleep, and the hypothalamic-pituitary-adrenal (HPA) axis. The study, conducted by Oregon Health & Science University, will enroll 60 participants aged 21-29 to assess daily sleep behaviors, cannabis use, and motivations using ecological momentary...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $233,250 to The Washington University in St. Louis to examine the relationship between early cannabis use and later opioid use disorder. The key objectives are to: 1) Estimate the association between early cannabis use and both proximal and distal aspects of opioid involvement, including whether the relationships are modified by co-occurring...
This federal Project Grant award of $2,118,992.00 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will fund a research project at the University of Miami to prospectively investigate the effects of cannabis use on reward and pain neurocircuits in adolescents with depression. The study aims to understand the relationships between cannabis use and depression in this population in order to inform prevention...
This $153,000 federal Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a 2-year longitudinal study to examine the relationship between cannabis use, pain perception, and daily functioning in young adults with chronic pain. The study will use an ecological momentary assessment burst design to capture real-time data on participants' cannabis use, pain, physical activity, and sleep over three 2-week...
This $177,110 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research on the impact of cannabis legalization and commercialization on substance use and mental health outcomes among individuals with psychosis. The principal investigator, an early career psychiatrist and health services researcher, will utilize quasi-experimental difference-in-difference methods to analyze national datasets,...
This $1,838,237 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to understand how chronic stress affects the neural circuits responsible for habit formation. The research aims to uncover the opposing amygdala-striatal pathways that mediate the impact of chronic stress on transitioning from goal-directed to habitual behaviors. Using a multifaceted approach including optical neuronal activity...

This $376,078 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to explore the relationship between cannabis use for coping purposes and quantity/frequency of cannabis use. The 5-year study, set to commence on August 1, 2024, will be conducted by the University of Colorado. Key objectives include:

  1. Experimentally testing whether cannabis use increases after stress induction among individuals who use cannabis for coping purposes.
  2. Examining if the relationship between stress and cannabis use is moderated by social anxiety and inhibitory control.
  3. Investigating whether cannabis use after stress reduces subjective and objective measures of stress.
  4. Exploring if decreases in stress are mediated by increased levels of the endocannabinoid arachidonoyl ethanolamide (AEA), and if this effect is influenced by the ratio of cannabidiol (CBD) to tetrahydrocannabinol (THC) in cannabis products.

The findings from this research are expected to inform intervention and prevention efforts for cannabis misuse, as well as contribute data on the potential harm reduction benefits of CBD.

Generated 7/1/25, 3:37 AM